Dietary Fat Modulation and Targeted Therapies for Prostate Cancer PreventionUsing pre-clinical models, our group has demonstrated that dietary fat reduction and decreasing the ratio ofomega-6 to omega-3 fatty acids impacts on the development and progression of prostate cancer. This workhas been translated into an ongoing clinical trial to determine if altering quantity and quality of dietary fateffects serum and prostate tissue nutrition-related, cancer-relevant biomarkers in men with prostate cancer.Based on data from our preclinical and clinical studies we postulate that the two main mechanisms underlyingthe anticancer effect of modulating dietary fat are through IGFBP-1-mediated inhibition of IGF signalling andthrough suppression of COX-2-dependent PGE-2 production. The primary aim of our present proposal is todetermine the contribution of the IGF/IGFBP and COX-2/PGE-2 pathways to the anticancer effect of dietaryfat modulation. We will accomplish this through a series of experiments utilizing (1) serum and prostatetissue obtained from an ongoing dietary-fat intervention trial in men with prostate cancer, (2) pathway-specific and tissue-specific genetically altered mouse prostate cancer models we developed targeting the IGFand COX-2 pathways that will be examined for dietary fat-responsiveness, (3) and androgen-dependentxenograft models in SCID mice that will be treated with dietary fat optimization combined with targeted IGFor COX-2 pharmaceuticals. Our proposed studies will be translated to a clinical trial testing the mostpromising combination of dietary fat modulation with a targeted molecular intervention, such as an antibodyto the IGF-1R or a COX-2 inhibitor, to evaluate effects on defined serum and tissue biomarkers. Our overallgoal is that these studies will lead directly to large scale, prospective clinical trials combining targetedtherapies with optimization of dietary fat to prevent the development and progression of prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA092131-06
Application #
7315072
Study Section
Special Emphasis Panel (ZCA1-RPRB-M (M1))
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
6
Fiscal Year
2007
Total Cost
$192,182
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Miller, Eric T; Salmasi, Amirali; Reiter, Robert E (2018) Anatomic and Molecular Imaging in Prostate Cancer. Cold Spring Harb Perspect Med 8:
Navarro, Héctor I; Goldstein, Andrew S (2018) HoxB13 mediates AR-V7 activity in prostate cancer. Proc Natl Acad Sci U S A 115:6528-6529
Mitra, Mithun; Ho, Linda D; Coller, Hilary A (2018) An In Vitro Model of Cellular Quiescence in Primary Human Dermal Fibroblasts. Methods Mol Biol 1686:27-47
Li, Jiayun; Speier, William; Ho, King Chung et al. (2018) An EM-based semi-supervised deep learning approach for semantic segmentation of histopathological images from radical prostatectomies. Comput Med Imaging Graph 69:125-133
Kang, Jung J; Reiter, Robert E; Kummer, Nicolas et al. (2018) Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy. Am J Clin Oncol 41:1-5
Lee, Ha Neul; Mitra, Mithun; Bosompra, Oye et al. (2018) RECK isoforms have opposing effects on cell migration. Mol Biol Cell 29:1825-1838
Aggarwal, Rahul; Huang, Jiaoti; Alumkal, Joshi J et al. (2018) Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study. J Clin Oncol 36:2492-2503
Cheng, Larry C; Li, Zhen; Graeber, Thomas G et al. (2018) Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer. J Vis Exp :
Park, Jung Wook; Lee, John K; Sheu, Katherine M et al. (2018) Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science 362:91-95
Tan, Nelly; Shen, Luyao; Khoshnoodi, Pooria et al. (2018) Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology. J Urol 199:1218-1223

Showing the most recent 10 out of 339 publications